Decoy Therapeutics (DCOY) Receivables (2016 - 2022)
Decoy Therapeutics (DCOY) reported Receivables of $1.6 million for Q3 2022, down 23.8% from $2.1 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Decoy Therapeutics (DCOY) Receivables (2016 - 2022) Analysis & Trends
Dating back to Q2 2016, Decoy Therapeutics' Receivables record includes 24 quarters.
- Receivables has a five-year compound annual growth rate of 165.3% (FY2016 to FY2021).
- By year, Receivables came in at $7.76 million in FY2020, $9,939 in FY2018 (-4.3%) and $10,385 in FY2017 (-14.7%).
- Five-year quarterly Receivables spans a low of $9,069 in Q1 2019 and a high of $7.76 million in Q4 2020.
- Year over year, Receivables has now declined in each of the last five quarters, with growth averaging 72.8% over the last seven quarters.
- The high point for year-over-year Receivables in five years was Q1 2021 (growth of 614.5%); the low point was Q4 2021 (a decline of 79.4%).
- Per Business Quant data, the three quarters before Q3 2022 came in at $1.6 million (Q2 2022), $1.6 million (Q1 2022) and $1.6 million (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.13 Bn | 1,102.72 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.88 Bn | 261.87 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.36 Bn | 235.05 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 235.80 Bn | 191.20 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.78 Bn | 164.97 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Decoy Therapeutics | 551,703.99 | -31.08 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 4.80 Mn |
| Mar 31, 2021 | 4.22 Mn |
| Dec 31, 2020 | 7.76 Mn |
| Sep 30, 2020 | 3.21 Mn |
| Jun 30, 2020 | 1.83 Mn |
| Mar 31, 2020 | 591,129.00 |
| Jun 30, 2019 | 28,278.00 |
| Mar 31, 2019 | 9,069.00 |
| Dec 31, 2018 | 9,939.00 |
| Sep 30, 2018 | 20,993.00 |
| Jun 30, 2018 | 17,329.00 |
| Mar 31, 2018 | 12,631.00 |
| Dec 31, 2017 | 10,385.00 |
| Sep 30, 2017 | 35,134.00 |
| Jun 30, 2017 | 34,735.00 |
API Access
Decoy Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=DCOY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "DCOY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=DCOY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();